Trial Profile
A study of allogeneic chimeric antigen receptor (CAR) T cells in the treatment of cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 May 2016
Price :
$35
*
At a glance
- Drugs T lymphocyte cell therapies (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 02 May 2016 I have added a drug class, as it is there are multiple targets so a specific Thes term is not available. Also multiple trials could be initiated in specific cancer types. Please modify accordingly.
- 02 May 2016 New trial record